Retinol-binding protein 4 in cardiovascular diseases: mechanisms and therapeutic perspectives

Area of Science:

• Biochemistry
• Cardiology
• Endocrinology

Background:

• Cardiovascular diseases (CVDs) are a leading global cause of mortality.
• Current diagnostic and management strategies for CVDs face significant challenges due to disease complexity.
• Retinol-binding protein 4 (RBP4), a retinol transporter, is increasingly implicated in CVD pathogenesis.

Purpose of the Study:

• To review the biological characteristics and roles of RBP4 in cardiovascular pathophysiology.
• To examine RBP4's potential as a diagnostic and prognostic biomarker for CVDs.
• To explore RBP4's implications for novel CVD prevention and treatment strategies.

Main Methods:

• Literature review of existing studies on RBP4 and cardiovascular diseases.
• Analysis of RBP4's biological functions and involvement in CVD risk factors.
• Examination of RBP4's utility as a biomarker and therapeutic target.

Main Results:

• RBP4 is involved in the pathogenesis of CVDs and associated risk factors.
• The precise mechanisms linking RBP4 to CVD progression are not fully understood.
• Evidence suggests RBP4 has potential as a biomarker for CVD diagnosis and prognosis.

Conclusions:

• RBP4 is a multifunctional protein with significant implications for cardiovascular health.
• Further research into RBP4 mechanisms is crucial for developing effective diagnostic and therapeutic interventions.
• Targeting RBP4 may offer new avenues for preventing and treating cardiovascular disorders.